ABVX:NASDAQ, ABIVAX Société Anonyme

ABVX stock overview

ABIVAX Société Anonyme (ABVX:NASDAQ) closed at $83.61 on November 16, 2026, down 4.53% on the day. The stock trades 43.8% below its 52-week high of $148.83 and 19.8% above its 52-week low of $69.81. Over the past year, it lost 26.5%. ABIVAX Société Anonyme is part of the Health Care sector.

Key figures

Price
$83.61
Day change
-4.53%
Volume
839,702
Average volume
1,091,539
Market cap
7B+
52-week range
$69.81 – $148.83
50-day average
$94.85
200-day average
$112.57

Price action over the past year

In 252 trading sessions since November 14, 2025, ABVX closed higher on 116 days (46%). Its best day was June 30, 2026 (+38.60%) and its worst was June 2, 2026 (-44.10%). The stock moved 10% or more in a single session 6 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

ABVX news

About ABIVAX Société Anonyme

Abivax is focused on developing innovative treatments that harness the body¿s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Similar stocks

Find more stocks like ABVX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.